Aurora Cannabis (TSE:ACB) Trading Down 0.7% – Here’s What Happened

Aurora Cannabis Inc. (TSE:ACB) dropped 0.7% during trading on Friday . The stock traded as low as C$4.48 and last traded at C$4.57. Approximately 309,967 shares were traded during mid-day trading, a decline of 24% from the average daily volume of 406,930 shares. The stock had previously closed at C$4.60.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group set a C$10.00 target price on Aurora Cannabis and gave the company a “buy” rating in a research note on Tuesday, January 27th. Two research analysts have rated the stock with a Buy rating, According to data from MarketBeat, the stock currently has a consensus rating of “Buy” and an average price target of C$9.25.

Aurora Cannabis Price Performance

The company has a current ratio of 3.06, a quick ratio of 2.48 and a debt-to-equity ratio of 25.02. The company has a 50 day moving average price of C$4.73 and a 200 day moving average price of C$5.53. The company has a market capitalization of C$270.21 million, a price-to-earnings ratio of -3.05 and a beta of 0.42.

Aurora Cannabis (TSE:ACB) last announced its quarterly earnings data on Wednesday, February 4th. The company reported C$0.03 EPS for the quarter. Aurora Cannabis had a negative return on equity of 1.15% and a negative net margin of 1.69%.The business had revenue of C$94.19 million during the quarter. As a group, equities research analysts forecast that Aurora Cannabis Inc. will post -0.22 earnings per share for the current year.

Aurora Cannabis Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.